Comment Submissions: 15-Day Notice of Modifications

This comment period was open from 06/10/2026 until 07/02/2026.

Notice

Proposed Rulemaking: Title 27 California Code of Regulations, Section 25705 No Significant Risk Level for 1-Bromopropane and Diethanolamine (Dermal)

Comments

Daniel Greenbaum and Thomas Adams on behalf of Greenbaum Law Firm glf-public-comment-re-dea.pdf

Emily Brandt commentemily-brandt.pdf

Independent Beauty Association (IBA) iba-oehha-dea-nsrl-modification-public-comment-260616.pdf

Personal Care Products Council

The Personal Care Products Council and the Consumer Healthcare Products Association 722026-pcpc-and-chpa-dea-comment.pdf